|
?:authorAffiliation
|
-
[\'Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.\', \'Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia.\', \'Department of Immunology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.\', \'Kirby Institute, University of New South Wales, Kensington, NSW, Australia.\', \'Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia.\', \'Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.\', \'Department of Microbiology and Infectious Diseases, Flinders University and SA Pathology, Flinders Medical Centre, Adelaide, SA, Australia.\', \'WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.\', \'Department of Immunology, SA Pathology, Flinders Medical Centre, Adelaide, SA, Australia.\', \'Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia. skent@unimelb.edu.au.\', \'Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia. skent@unimelb.edu.au.\', \'Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia. skent@unimelb.edu.au.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}